A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients. [electronic resource]
Producer: 19971023Description: 495-500 p. digitalISSN:- 0272-6386
- Anabolic Agents -- administration & dosage
- Anemia -- drug therapy
- Drug Therapy, Combination
- Epoetin Alfa
- Erythropoietin -- administration & dosage
- Female
- Hematocrit
- Humans
- Kidney Failure, Chronic -- complications
- Male
- Middle Aged
- Nandrolone -- administration & dosage
- Nandrolone Decanoate
- Prospective Studies
- Recombinant Proteins
- Renal Dialysis
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.